UNSPSC 51383801: Adapalene

This classification denotes a retinoic acid agent with the molecular formula C28H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1L4806J2QF, chemically known as 2-naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)- but generally known as adapalene, which bears US NIH Compound Identifier 60164. European Medicines Agency schedules Adapalene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05261MIG.

UNSPSC 51383801 Adapalene is a Commodity code that represents pharmaceutical active ingredients and topical dermatological agents, but recent state and local procurement activity tagged under this code shows no clear alignment with adapalene itself. The single recent solicitation on record involves naloxone and drug deactivation systems rather than dermatological products, suggesting either a misclassification in the issuing body's tagging or limited current demand for adapalene through formal state and local channels. When state and local governments do procure under pharmaceutical commodity codes in this family, they typically source finished drugs, medical supplies, and emergency response pharmaceuticals for public health programs, community health departments, and first-responder networks.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023, and the procurement included standard state and local compliance requirements such as drug-free workplace certification, E-Verify, and commercial general liability insurance. The contract offered a two-year initial term with a one-year renewal option and was potentially funded through FEMA, introducing federal compliance obligations. No recent opportunities specifically targeting adapalene or other topical dermatological agents appear in current state and local procurement records, suggesting minimal near-term activity under this code's nominal scope.